[Expression of Concern] Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma
Oncology Letters · 03.07.2026 · 32 (3) · 1-1
DOI: 10.3892/ol.2026.15744 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 03.07.2026. Verfasst von Yumiko Kondo und 8 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kondo, Y., Honoki, K., Kishi, S., Mori, S., Fujiwara-Tani, R., Tsukamoto, S., Fujii, H., Kuniyasu, H., & Tanaka, Y. (2026). [Expression of Concern] Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma. Oncology Letters, 32(3), 1-1. https://doi.org/10.3892/ol.2026.15744
Vancouver
Kondo Y, Honoki K, Kishi S, Mori S, Fujiwara-Tani R, Tsukamoto S, et al. [Expression of Concern] Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma. Oncology Letters. 2026;32(3):1-1. doi:10.3892/ol.2026.15744
BibTeX
@article{Kondo2026,
author = {Kondo, Yumiko and Honoki, Kanya and Kishi, Shingo and Mori, Shiori and Fujiwara-Tani, Rina and Tsukamoto, Shinji and Fujii, Hiromasa and Kuniyasu, Hiroki and Tanaka, Yasuhito},
title = {[Expression of Concern] Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma},
journal = {Oncology Letters},
year = {2026},
volume = {32},
number = {3},
pages = {1--1},
doi = {10.3892/ol.2026.15744}
}
EUVIMED